Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent stem cells.

Rajesh D, Dickerson SJ, Yu J, Brown ME, Thomson JA, Seay NJ.

Blood. 2011 Aug 18;118(7):1797-800. doi: 10.1182/blood-2011-01-332064. Epub 2011 Jun 27.

2.

Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.

Niller HH, Wolf H, Minarovits J.

Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Review.

PMID:
18432410
3.

Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.

Kalla M, Hammerschmidt W.

Eur J Cell Biol. 2012 Jan;91(1):65-9. doi: 10.1016/j.ejcb.2011.01.014. Epub 2011 Mar 29. Review.

PMID:
21450364
4.

A supporting role of Chinese National Immortalized Cell Bank in life science research.

Chongfeng X, Ziyuan D.

Yi Chuan. 2017 Jan 20;39(1):75-86. doi: 10.16288/j.yczz.16-391. Review.

PMID:
28115308
5.

Modeling Viral Infectious Diseases and Development of Antiviral Therapies Using Human Induced Pluripotent Stem Cell-Derived Systems.

Trevisan M, Sinigaglia A, Desole G, Berto A, Pacenti M, Pal├╣ G, Barzon L.

Viruses. 2015 Jul 13;7(7):3835-56. doi: 10.3390/v7072800. Review.

6.
7.

In vitro human cell line models to predict clinical response to anticancer drugs.

Niu N, Wang L.

Pharmacogenomics. 2015;16(3):273-85. doi: 10.2217/pgs.14.170. Review.

Supplemental Content

Support Center